Patient Presentation

2013 ACC/AHA Cholesterol Guidelines

4 Major Statin Benefit Groups

Timelines of Lipid-Lowering Agents

Evolution of Therapeutic Monoclonal Antibodies

PCSK9 Inhibition in Patients With Hypercholesterolemia Receiving

Statin Therapy

Effect of PCSK9-Inhibitor Monotherapy on Lipid Parameters

Clinical Considerations for PCSK9 Inhibitors

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)